1338586-49-4

Basic information

• Product Name: 2-chloro-2',3'-isopropylidene-N⁶-cyclohexyladenosine
• Synonyms: 2-chloro-2',3'-isopropylidene-N⁶-cyclohexyladenosine
• CAS NO: 1338586-49-4
• Molecular Weight: 423.9
• Mol File: 1338586-49-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-chloro-2',3'-isopropylidene-N⁶-cyclohexyladenosine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-2',3'-isopropylidene-N⁶-cyclohexyladenosine(1338586-49-4)
• EPA Substance Registry System: 2-chloro-2',3'-isopropylidene-N⁶-cyclohexyladenosine(1338586-49-4)

Safety Data

• Hazardous Substances Data: 1338586-49-4(Hazardous Substances Data)

Upstream product

• 77-76-9 2,2-dimethoxy-propane 
• 67-64-1 acetone 
• 38583-85-6 2-chloro-N⁶-cyclohexyladenosine 
• 13276-52-3 2,6-dichloropurine riboside 
• 108-91-8 cyclohexylamine 

Downstream Products

• 1254160-17-2 sodium ((2R,3S,4R,5R)-5-(2-chloro-6-(cyclohexylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl sulfate 

Relevant articles and documents

METHODS OF PREVENTING, REDUCING OR TREATING MACULAR DEGENERATION

The present invention is directed to selective adenosine A1 agonist compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat, reduce or prevent age-related macular degeneration.

METHOD OF REDUCING INTRAOCULAR PRESSURE IN HUMANS

Provided herein are compounds of Formula I, compositions comprising an effective amount of a compound of Formula I, and methods for reducing intraocular pressure comprising administering an effective amount of compounds of Formula I to a subject in need t